Overview
The Drug Development Phase 2 module is part of the DIA Drug Development and Lifecycle Management eLearning Program. In this module, learners will learn about the factors that drive the design and conduct of phase 2 clinical trials, as well as the activities and functional areas that contribute to a successful phase 2 program.
Estimated time to complete module: 1.25 hours
This eLearning module can be purchased individually or as part of the Drug Development and Lifecycle Management eLearning Program.
Have an account?